Mercado de tos crónica: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00011584
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

Se espera que el mercado de la tos crónica alcance los 9.854,8 millones de dólares en 2027, frente a los 5.430,0 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 7,8 % entre 2020 y 2027.

La tos crónica se define como una tos persistente que dura hasta 6 a 8 semanas. Afecta significativamente la vida de los pacientes al interrumpir el sueño, crear sensación de vómitos, aturdimiento e incluso fracturas de costillas. Se debe a múltiples motivos, como infecciones, asma y enfermedad por reflujo gastroesofágico (ERGE). El crecimiento del mercado de la tos crónica se atribuye a factores como el aumento de la incidencia de la tos crónica y se espera que el creciente desarrollo de productos para tratar la tos crónica impulse el crecimiento del mercado. Sin embargo, las retiradas de productos son el principal factor que obstaculiza el crecimiento del mercado.

Mercados regionales lucrativos para la tos crónica

MarketInsights

Incidencia creciente de tos crónica

La tos crónica es causada por asma, reflujo ácido del estómago y goteo posnasal. También es probable que afecciones como infecciones, bronquitis y enfermedades pulmonares provoquen tos crónica. Enfermedades como el asma están aumentando en todo el mundo; se ve comúnmente entre niños y adultos. Es una de las principales causas de la creciente carga sanitaria en Estados Unidos. Por ejemplo, según datos de los Centros para el Control y la Prevención de Enfermedades (CDC) publicados en 2019, una de cada tres personas tiene asma en EE. UU. En todo Estados Unidos, más de 25 millones de personas viven con asma, lo que representa aproximadamente el 8 % en adultos y casi el 8,5 % en niños.

En regiones en desarrollo como Asia Pacífico y En Oriente Medio y África, la prevalencia de enfermedades crónicas está aumentando debido a la contaminación y las infecciones. Los países de estas regiones están altamente poblados. Si bien la tos es una enfermedad no transmisible, está aumentando significativamente en los países. Varios gobiernos están poniendo sus esfuerzos para controlar la incidencia de la tos crónica en los respectivos países. Según la Política Nacional de Salud de 2017, la mortalidad prematura debida a enfermedades no transmisibles, incluida la tos crónica, se reducirá en aproximadamente un 25% para 2025.

En el Medio Oriente y África, las enfermedades respiratorias están aumentando debido a las condiciones climáticas. Los países rodeados de postres son propensos al riesgo de enfermedades respiratorias debido a la fácil propagación de alérgenos. Más del 60 al 70% de los pacientes en los países son diagnosticados con enfermedades respiratorias. Otra causa importante de tos crónica entre la población de la región es el tabaquismo. Casi el 30% de las personas son adictas al tabaquismo, lo que conduce aún más a un aumento de la incidencia de tos crónica.

Información sobre las clases de fármacos

< p> Según la clase de fármaco, el mercado de la tos crónica se segmenta en antihistamínicos, contorsionistas, descongestionantes, fármacos combinados, antibióticos, bloqueadores de ácido y otras clases de fármacos. El segmento de medicamentos combinados tuvo la mayor participación del mercado en 2019 y se estima que el mismo segmento reportará la CAGR más alta del mercado durante el período de pronóstico. El crecimiento del segmento se estima debido a los beneficios que ofrecen los medicamentos combinados, como el uso de medicamentos combinados que pueden apuntar al tratamiento de más de un síntoma. Además, la combinación de medicamentos está ampliamente disponible como medicamentos de venta libre.

Mercado mundial de la tos crónica, por clase de medicamento: 2019 y 2027

Ruta de información sobre la administración

Según la vía de administración, el mercado de la tos crónica se segmenta en vía oral, inyecciones, inhalación y otras vías de administración. El segmento oral tuvo la mayor participación del mercado en 2019. Sin embargo, se estima que el segmento de inhalación registrará la CAGR más alta del mercado durante el período de pronóstico.

Información sobre el canal de distribución

Según el canal de distribución, el mercado de la tos crónica se segmenta en farmacia hospitalaria, farmacia en línea y farmacia minorista. El segmento de farmacia hospitalaria tuvo la mayor participación del mercado en 2019. Sin embargo, se estima que el segmento de farmacia en línea registrará la CAGR más alta del mercado durante el período de pronóstico.

< h3>Información estratégica

Las estrategias inorgánicas son las estrategias más comúnmente adoptadas por las empresas en el mercado de la tos crónica, lo que les permite ampliar su huella global y sus carteras de productos y servicios. Los actores del mercado también han adoptado estrategias orgánicas, como la estrategia de lanzamiento de productos, para ampliar su base global de clientes, lo que también les permite mantener su marca a nivel mundial.

Mercado global de tos crónica y ndash ; Por clase de medicamento

  • Antihistamínicos
  • Corticosteroides
  • Descongestionantes
  • Medicamento combinado
  • Antibióticos
  • Bloqueadores de ácido
  • Otra clase de fármaco

Mercado mundial de la tos crónica: Por Vía de Administración

  • Inyecciones
  • Oral
  • Nasal
  • Otra vía de administración

Mercado mundial de la tos crónica: Por Canal de Distribución

  • Farmacia Hospitalaria
  • Farmacia en línea
  • Farmacia minorista

Crónica < /em>Mercado de la tos– Por geografía

  • América del Norte

    • Estados Unidos
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
  • Oriente Medio y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
  • América del Sur y Central
    • Brasil
    • Argentina

Perfiles de la empresa

  • Novartis AG

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is chronic cough?

Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others.

What are the driving factors for the chronic cough market across the globe?

The growth of market is likely to grow due to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recall is the major factor hindering the market growth.

What is the average cost of chronic cough medicines?

The cost of chronic cough medicine starts from US$ 2 and above. The price of medicine depends upon the type of drug, whether it is tablet, syrup, or nasal spray. The generic and OTC drugs are much cheaper compared to the branded and prescribed ones.

The List of Companies - Chronic Cough Market

  1. Novartis AG
  2. Teva Pharmaceutical Industries Ltd
  3. Glaxo Smith Klineplc.
  4. Bayer AG
  5. Mylan N.V.
  6. Amneal Pharmaceuticals, Inc.
  7. Cipla Inc.
  8. Reckitt Benckiser Group plc.
  9. Sun Pharmaceutical Industries Ltd
  10. AurobindoPharma Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports